U.S. Centers for Disease Control and Prevention Selects Verily to Support National Wastewater Monitoring
Verily, an Alphabet precision health technology company, today announced it was selected by the Centers for Disease Control (CDC) to support the agency’s National Wastewater Surveillance System (NWSS).
- Verily, an Alphabet precision health technology company, today announced it was selected by the Centers for Disease Control (CDC) to support the agency’s National Wastewater Surveillance System (NWSS).
- The CDC launched NWSS in September 2020 to coordinate and build the nation’s capacity to track the presence of SARS-CoV-2 in wastewater samples collected across the country.
- Verily’s Wastewater program offers wastewater surveillance to test for pathogens present in wastewater treatment facilities nationwide, allowing for timely detection and monitoring to inform public health actions.
- Verily’s Wastewater program provides a robust measure of community infection trends at the height of surges when clinical testing can have insufficient capacity.